Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative sequential tranexamic acid in joint arthroplasty by fibrinolytic phenotype
ChiCTR2300073045Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Chongqing Medical University
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tranexamic acid in arthroplasty (4 arms), sponsored by First Affiliated Hospital of Chongqing Medical University. Primary endpoint: Blood loss. Planned start Jul 2023; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
arthroplasty
Beyond the preview
Go deeper on ChiCTR2300073045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073045.